Finished

Performance Attributes and User Progression While Using Ekso

NCT02132702 · Ekso Bionics · Updated 8 Oct 2024

What is being tested: Ekso
For: Spinal Cord Injury
Kind of study: Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join: Ages 15 years to 65 years. About 60 people. The full rules are on the registry page.
Where: Denmark, Germany, Netherlands, Norway, Spain, Sweden, Switzerland (9 sites)
When: Starts or started Aug 2014, ends Jan 2017. Registered 7 May 2014.
Results: Posted on the registry on 8 Oct 2024.

In the researchers' words

This study is to evaluate the performance attributes and user progression of participants with motor complete and incomplete spinal cord injury (SCI) while utilizing the Ekso robotic exoskeleton in an eight week over ground, locomotor program. We hypothesize an improvement in progression and overall health while using Ekso.

ClinicalTrials.gov, NCT02132702

Sites

Glostrup HospitalHornbæk, Denmark
Universitats-und RehabilitationsklinikenUlm, Germany
Heliomare RevalidatieWijk aan Zee, Netherlands
Sunnaas Sykehus HFOslo, Norway
Institut Guttmann, Neurorehabilitation HospitalBarcelona, Spain
Fundacion Lesionado MedularMadrid, Spain
Clinical Department of Rehabilitation Medicine and Department of Medicine and Health ServicesLinköping, Sweden
Sinalenheten, Akademiska SjukhusetUppsala, Sweden
Swiss Paraplegic Center (SPZ)Nottwil, Switzerland